On July 7, the Parliament voted in the final reading the draft law no. 77/2023 amending Fiscal Code and the Law on the customs tariff
The law clarified that, in all cases, products must be qualified in customs as medicines if they were previously registered in the State Nomenclature of Medicines or were authorized for import by the Medicines and Medical Devices Agency, regardless of the tariff position assigned according to the Combined Nomenclature of Goods.
This new approach will allow to avoid the abuses regularly admitted in customs.
AmCham was the promoter of these changes, considering the intervention as necessary and well-argued and the intervention method as one of the most suitable for solving the problems raised by the business community concerning the uneven customs qualification practices of medicines.
AmCham thanks the Medicines and Medical Devices Agency, the Ministry of Finance, and the Parliament of the Republic of Moldova for collaboration.